APOE Genotype Specific Effects on the Early Neurodegenerative Sequelae Following Chronic Repeated Mild Traumatic Brain Injury. (15th April 2019)

• Record Type: Journal Article
• Authors: Muza, Phillip; Bachmeier, Corbin; Mouzon, Benoit; Algamal, Moustafa; Rafi, Naomi G.; Lungmus, Carlyn; Abdullah, Laila; Evans, James E.; Ferguson, Scott; Mullan, Michael; Crawford, Fiona; Ojo, Joseph O.
• Is Part Of: Neuroscience. Volume 404(2019)
• Page Start: 297
• Page End: 313
• Publication Date: 2019-04-15
• Subjects: AD Alzheimer's disease -- APOE apolipoprotein -- AQ4 aquaporin 4 -- CTE chronic traumatic encephalopathy -- EAAT2 excitatory amino acid transporter 2 -- IHC immunohistochemistry -- MUFA monounsaturated fatty acids -- PUFA polyunsaturated fatty acids -- SFA saturated fatty acids -- R-mTBI repeated mild traumatic brain injury; APOE4 -- astrocytes -- mild TBI -- microglia -- phospholipid -- tau; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2019.01.049
• Languages: English
• ISSNs: 0306-4522

Abstract

Abstract: Repeated mild traumatic brain injury (r-mTBI) can potentially manifest into chronic traumatic encephalopathy (CTE). The apolipoprotein E (APOE4) genotype, a well-recognized potent genetic risk factor in age-related neurodegenerative diseases such as Alzheimer's disease, has been linked to worse outcome after TBI in individuals who carry this allele. The underlying molecular modifications triggered by APOE genotype following r-mTBI remain elusive. We addressed the influence of APOE genotype on TBI dependent tau pathology in middle-aged mice. Using a previously established experimental mTBI protocol in a new repetitive injury paradigm, we report the pathological changes that occurred following one-month of repetitive injuries in APOE3/4 gene targeted mice. Firstly, pathological assessment demonstrated evidence of microgliosis and astrogliosis in the corpus callosum of injured animals, but there was no APOE dependent genotype effect on injury. However, in the parietal cortex Iba1-immunoreactivity was significantly increased in injured versus sham APOE3 mice, but not in APOE4 mice. No effects were observed in soluble amyloid levels with injury or interaction with genotype. APOE4 mice showed significant increases in the tau conformational marker MC1, neurofilament H, brain phospholipids, and endothelial specific oxidized low density lipoprotein receptor in cortical homogenates obtained from injured mice compared to sham counterparts. This pilot work suggests APOE3 and APOE4 specific effects following injury in a mouse model of r-mTBI. These changes may underlie the molecular changes that trigger the vulnerability and increased risk of developing neurodegenerative diseases in aged individuals exposed to repetitive mTBI. Highlights: APOE4 genotype diminishes activation of microglia in the cortex of injured mice. APOE4 mice have increased levels of MC1 + conformational tau species following injury. APOE genotype impacts levels of brain phospholipids and lectin-like oxidized LDL receptor-1 following injury.